Cargando…
Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177613/ https://www.ncbi.nlm.nih.gov/pubmed/28066719 http://dx.doi.org/10.3389/fonc.2016.00263 |
| _version_ | 1782485023624003584 |
|---|---|
| author | Kunos, Charles A. |
| author_facet | Kunos, Charles A. |
| author_sort | Kunos, Charles A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5177613 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51776132017-01-06 Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer Kunos, Charles A. Front Oncol Oncology Frontiers Media S.A. 2016-12-22 /pmc/articles/PMC5177613/ /pubmed/28066719 http://dx.doi.org/10.3389/fonc.2016.00263 Text en Copyright © 2016 Kunos. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Kunos, Charles A. Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer |
| title | Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer |
| title_full | Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer |
| title_fullStr | Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer |
| title_full_unstemmed | Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer |
| title_short | Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer |
| title_sort | commentary: phase i trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177613/ https://www.ncbi.nlm.nih.gov/pubmed/28066719 http://dx.doi.org/10.3389/fonc.2016.00263 |
| work_keys_str_mv | AT kunoscharlesa commentaryphaseitrialofcarboplatinandgemcitabinechemotherapyandstereotacticablativeradiosurgeryforthepalliativetreatmentofpersistentorrecurrentgynecologiccancer |